IRVINE, CA / ACCESSWIRE / August 30, 2017 / Khang & Khang LLP (the “Firm”) announces a securities class action lawsuit against IntelliPharmaCeutics International Inc. (“IntelliPharmaCeutics” or the “Company”) (NASDAQ: IPCI). Investors who purchased or otherwise acquired shares from January 14, 2016 through July 26, 2017, inclusive (the “Class Period”), are encouraged to contact the Firm in advance of the September 29, 2017 lead
plaintiff motion deadline.

If you purchased IntelliPharmaCeutics shares during the Class Period, please contact Joon M. Khang, Esq., of Khang & Khang LLP, 4000 Barranca Parkway, Suite 250, Irvine, CA 92604, by telephone at (949) 419-3834, or by e-mail at joon@khanglaw.com.

There has been no class certification in this case yet. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member as well.

According to the Complaint, throughout the Class Period, IntelliPharmaCeutics made false and/or misleading statements and/or failed to disclose: that the Company failed to conduct a human abuse liability study to support its New Drug Application (“NDA”) for Rexista; that IntelliPharmaCeutics did not include abuse-deterrent studies conducted to suppose abuse-deterrent label claims related to abuse of the drug by various pathways; that the Company was not submitting sufficient data to support approval of the NDA; and that as a result of the above, the Company’s statements about its business, operations, and prospects were false and misleading and/or lacked a reasonable basis.

On July 24, 2017, scientists from the Food & Drug Administration (“FDA”) expressed concerns that the Company failed to provide enough data about the abuse potential of its opioid painkilling drug, Rexista. On July 26, 2017, IntelliPharmaCeutics announced that two advisory committees of the FDA voted 22 to 1 to oppose the Company’s NDA for Rexista, citing insufficient data regarding the abuse-deterrent properties of the drug as a motivating concern. Upon release of this news, the Company’s share price lowered materially, which caused investors harm according to the Complaint.

If you wish to learn more about this lawsuit, or if you have questions about this notice or your rights, please contact Joon M. Khang, Esq., a prominent litigator for nearly two decades, by telephone at (949) 419-3834, or via e-mail at joon@khanglaw.com.

This press release may be considered Attorney Advertising in certain jurisdictions.

Contact

Joon M. Khang, Esq.

Telephone: 949-419-3834

Facsimile: 949-225-4474

joon@khanglaw.com

SOURCE: Khang & Khang LLP

ReleaseID: 474232

IRVINE, CA / ACCESSWIRE / August 30, 2017 / Khang & Khang LLP (the “Firm”) announces a securities class action lawsuit against Electronics for Imaging, Inc. (“Electronics for Imaging” or the “Company”) (NASDAQ: EFII). Investors who purchased or otherwise acquired shares between February 22, 2017 and August 3, 2017, inclusive (the “Class Period”), are encouraged to contact the Firm in advance of the October 10, 2017 lead plaintiff motion deadline.

If you purchased Electronics for Imaging shares during the Class Period, please contact Joon M. Khang, Esq., of Khang & Khang LLP, 4000 Barranca Parkway, Suite 250, Irvine, CA 92604, by telephone at (949) 419-3834, or by e-mail at joon@khanglaw.com.

There has been no class certification in this case yet. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member as well.

According to the Complaint, throughout the Class Period, Electronics for Imaging made false and/or misleading statements and/or failed to disclose: that the Company was improperly recognizing revenue; that the Company’s disclosure controls and procedures were not effective; that the Company’s internal control over financial reporting were not effective; and thus, the Company’s public statements were materially false and misleading at all relevant times. On August 3, 2017, Electronics for Imaging notified investors that it was postponing a conference call in which it anticipated discussing second quarter 2017 preliminary results. The Company announced that its audit committee is conducting an independent review of the effectiveness of disclosure controls and internal controls over financial reporting. The problems identified by the audit committee include assessing timing of revenue recognition related to certain transactions, and therefore the Company may not be able to file its quarterly report on time. When this news went public, Electronics for Imaging’s share price decreased materially, which caused investors harm according to the Complaint.

If you wish to learn more about this lawsuit, or if you have any questions concerning this notice or your rights, please contact Joon M. Khang, Esq., a prominent litigator for almost two decades, by telephone at (949) 419-3834, or by e-mail at joon@khanglaw.com.

This press release may constitute Attorney Advertising in some jurisdictions.

Contact

Joon M. Khang, Esq.

Telephone: 949-419-3834

Facsimile: 949-225-4474

joon@khanglaw.com

SOURCE: Khang & Khang LLP

ReleaseID: 474233

IRVINE, CA / ACCESSWIRE / August 30, 2017 / Khang & Khang LLP (the “Firm”) announces a securities class action lawsuit against Sequans Communications S.A. (“Sequans” or the “Company”) (NYSE: SQNS). Investors who purchased or otherwise acquired Sequans shares between April 29, 2016 and July 31, 2017, inclusive (the “Class Period”), are encouraged to contact the Firm in advance of the October 10, 2017 lead plaintiff motion deadline.

If you purchased Sequans shares during the Class Period, please contact Joon M. Khang, Esq., of Khang & Khang LLP, 4000 Barranca Parkway, Suite 250, Irvine, CA 92604, by telephone at (949) 419-3834, or by e-mail at joon@khanglaw.com.

There has been no class certification in this case yet. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member as well.

According to the Complaint, throughout the Class Period, Sequans made false and/or misleading statements, and/or failed to disclose, that the Company was improperly recognizing revenue, and as a result, its public statements were materially false and misleading at all relevant times. On August 1, 2017, Sequans revealed that its revenue in the second quarter was negatively affected by a product return from an early 2016 sale related to the tablet business. When this news was announced to the public, shares of Sequans declined in value materially, which caused investors harm according to the Complaint.

If you wish to learn more about this lawsuit, or if you have any questions about this notice or your rights, please contact Joon M. Khang, Esq., a prominent litigator for nearly two decades, by telephone at (949) 419-3834, or by e-mail at joon@khanglaw.com.

This press release may constitute Attorney Advertising in certain jurisdictions.

Contact

Joon M. Khang, Esq.

Telephone: 949-419-3834

Facsimile: 949-225-4474

joon@khanglaw.com

SOURCE: Khang & Khang LLP

ReleaseID: 474235

IRVINE, CA / ACCESSWIRE / August 30, 2017 / Khang & Khang LLP (the “Firm”) announces a securities class action lawsuit against Chipotle Mexican Grill, Inc. (“Chipotle” or the “Company”) (NYSE: CMG). Investors who purchased or otherwise acquired Chipotle shares from February 5, 2016 through July 19, 2017, inclusive (the “Class Period”), are encouraged to contact the Firm before the September 18, 2017 lead
plaintiff motion deadline.

If you purchased Chipotle shares during the Class Period, please contact Joon M. Khang, Esq., of Khang & Khang LLP, 4000 Barranca Parkway, Suite 250, Irvine, CA 92604, by telephone at (949) 419-3834, or by e-mail at joon@khanglaw.com.

There has been no class certification in this case yet, and until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member as well.

According to the lawsuit, throughout the Class Period, Chipotle made false and/or misleading statements and/or failed to disclose: that the Company’s purported improvements in its food safety policies were inadequate; that Chipotle’s quality controls were not in compliance with applicable consumer and workplace safety regulations; that the quality controls remained insufficient to safeguard consumer and employee health; and that as a result, Chipotle’s public statements were materially false and misleading at all relevant times. When this information reached the public, Chipotle’s stock price fell materially, which harmed investors according to the Complaint.

If you wish to learn more about this lawsuit, or if you have questions about this notice or your rights, please contact Joon M. Khang, Esq., a prominent litigator for nearly two decades, by telephone at (949) 419-3834, or by e-mail at joon@khanglaw.com.

This press release may be considered Attorney Advertising in certain jurisdictions.

Contact

Joon M. Khang, Esq.

Telephone: 949-419-3834

Facsimile: 949-225-4474

joon@khanglaw.com

SOURCE: Khang & Khang LLP

ReleaseID: 474231

LOS ANGELES, CA / ACCESSWIRE / August 30, 2017 / Lundin Law PC, a shareholder rights firm, announces a class action lawsuit against TechnipFMC plc (“TechnipFMC” or the “Company”) (NYSE: FTI) regarding possible violations of federal securities laws from April 27, 2017 through July 24, 2017, inclusive (the “Class Period”). Investors who purchased or otherwise acquired TechnipFMC shares during the Class Period should contact the firm prior to the October 2, 2017 lead plaintiff motion deadline.

To participate in this class action lawsuit, click here.

You can also call Brian Lundin, Esq., of Lundin Law PC, at 888-713-1033, or e-mail him at brian@lundinlawpc.com.

No class has been certified in the above action yet. Until a class is certified, you are not considered to be represented by an attorney. You may also choose to do nothing and be an absent class member.

According to the Complaint, throughout the Class Period, TechnipFMC made false and/or misleading statements, and/or failed to disclose that: the Company had a material weakness in its internal control over rates used in the calculations of the foreign currency effects on certain of its engineering and construction projects; that TechnipFMC lacked effective internal controls over financial reporting; and that as a result of the above, the Company’s public statements were materially false and misleading at all relevant times. When this information went public, shares of TechnipFMC decreased in value materially, which caused investors harm according to the Complaint.

Lundin Law PC was founded by Brian Lundin, Esq., a securities litigator based in Los Angeles dedicated to upholding shareholders’ rights.

This press release may be considered Attorney Advertising in certain jurisdictions under the applicable law and ethics rules.

Contact:

Lundin Law PC

Brian Lundin, Esq.

Telephone: 888-713-1033

Facsimile: 888-713-1125

brian@lundinlawpc.com
http://lundinlawpc.com/

SOURCE: Lundin Law PC

ReleaseID: 474222

LOS ANGELES, CA / ACCESSWIRE / August 30, 2017 / Lundin Law PC, a shareholder rights firm, announces the filing of a class action lawsuit against Blue Apron Holdings, Inc. (”Blue Apron” or the ”Company”) (NYSE: APRN) regarding possible violations of federal securities laws in connection with its initial public offering (the ”IPO”). Investors who purchased or otherwise acquired shares pursuant or traceable to the IPO, should contact the firm prior to the October 16, 2017 lead plaintiff motion deadline.

To participate in this class action lawsuit, click here.

You can also call Brian Lundin, Esq., of Lundin Law PC, at 888-713-1033, or you can e-mail him at brian@lundinlawpc.com.

No class has been certified in the above action yet. Until a class is certified, you are not considered represented by an attorney. You may also choose to do nothing and be an absent class member.

According to the Complaint, the Registration Statement filed in connection with the IPO failed to disclose that: Blue Apron decided to significantly reduce spending on advertising in Q2 2017, hurting sales and profit margins in future quarters; that the Company was experiencing difficulty with customer retention due to orders not arriving on time or with all expected ingredients; and that the Company was experiencing delayed orders in Q2 2017 related to its new factory in Linden, New Jersey. Since the IPO, Blue Apron’s stock price has fallen materially, which caused investors harm according to the Complaint.

Lundin Law PC was founded by Brian Lundin, Esq., a securities litigator based in Los Angeles dedicated to upholding shareholders’ rights.

This press release may be considered Attorney Advertising in certain jurisdictions under the applicable law and ethics rules.

Contact:

Lundin Law PC
Brian Lundin, Esq.
Telephone: 888-713-1033
Facsimile: 888-713-1125
brian@lundinlawpc.com
http://lundinlawpc.com/

SOURCE: Lundin Law PC

ReleaseID: 474221

LOS ANGELES, CA / ACCESSWIRE / August 30, 2017 / Lundin Law PC, a shareholder rights firm, announces a class action lawsuit against The Advisory Board Company (“Advisory Board” or the “Company”) (NASDAQ: ABCO) for possible violations of federal securities laws between January 21, 2015 and February 23, 2016, inclusive (the “Class Period”). Investors who purchased or otherwise acquired Advisory Board shares during the Class Period should contact the firm prior to the October 2, 2017 lead plaintiff motion deadline.

To participate in this class action lawsuit, click here.

You can also call Brian Lundin, Esq., of Lundin Law PC, at 888-713-1033, or you can e-mail him at brian@lundinlawpc.com.

No class has been certified in the above action yet. Until a class is certified, you are not considered to be represented by an attorney. You may also choose to do nothing and be an absent class member.

According to the Complaint, throughout the Class Period, Advisory Board made materially false and/or misleading statements and/or failed to disclose that there were severe integration problems associated with its acquisition of Royall and, as a consequence of these integration problems, the Company had no basis to increase the revenue guidance for Royall during the Class Period. When this information reached the public, shares of Advisory Board dropped in value materially, which caused investors harm according to the Complaint.

Lundin Law PC was established by Brian Lundin, Esq., a securities litigator based in Los Angeles dedicated to upholding shareholders’ rights.

This press release may constitute Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

Contact:

Lundin Law PC

Brian Lundin, Esq.

Telephone: 888-713-1033

Facsimile: 888-713-1125

brian@lundinlawpc.com
http://lundinlawpc.com/

SOURCE: Lundin Law PC

ReleaseID: 474224

LOS ANGELES, CA / ACCESSWIRE / August 30, 2017 / Lundin Law PC, a shareholder rights firm, announces a class action lawsuit against Envision Healthcare Corporation (”Envision” or the ”Company”) (NYSE: EVHC) for possible violations of federal securities laws between March 2, 2015 and July 21, 2017, inclusive (the ”Class Period”). Investors who purchased or otherwise acquired Envision shares during the Class Period should contact the firm prior to the October 3, 2017 lead plaintiff motion deadline.

To participate in this class action lawsuit, click here.

You can also call Brian Lundin, Esq., of Lundin Law PC, at 888-713-1033, or e-mail him at brian@lundinlawpc.com.

No class has been certified in the above action yet. Until a class is certified, you are not considered to be represented by an attorney. You may also choose to do nothing and be an absent class member.

According to the Complaint, throughout the Class Period, Envision made materially false and/or misleading statements, and/or failed to disclose material information, about its business, operations and compliance policies. On July 24, 2017, The New York Times reported that hospitals associated with the Company’s subsidiary, EmCare Holdings, Inc., were disproportionately likely to engage in ”surprise billing,” in which patients seeking treatment at in-network facilities were treated by out-of-network physicians and then billed at higher rates. When this news went public, Envision’s shares lowered in value materially, which caused investors harm according to the Complaint.

Lundin Law PC was founded by Brian Lundin, Esq., a securities litigator based in Los Angeles dedicated to upholding shareholders’ rights.

This press release may be considered Attorney Advertising in certain jurisdictions under the applicable law and ethics rules.

Contact:

Lundin Law PC

Brian Lundin, Esq.

Telephone: 888-713-1033

Facsimile: 888-713-1125

brian@lundinlawpc.com
http://lundinlawpc.com/

SOURCE: Lundin Law PC

ReleaseID: 474223

LOS ANGELES, CA / ACCESSWIRE / August 30, 2017 / Lundin Law PC, a shareholder rights firm, announces the filing of a class action lawsuit against Acacia Communications, Inc. (”Acacia” or the ”Company”) (NASDAQ: ACIA) concerning possible violations of federal securities laws between August 11, 2016 and July 13, 2017, inclusive (the ”Class Period”). Investors who purchased or otherwise acquired Acacia shares during the Class Period should contact the firm prior to the October 13, 2017 lead plaintiff motion deadline.

To participate in this class action lawsuit, click here.

You can also call Brian Lundin, Esq., of Lundin Law PC, at 888-713-1033, or you can e-mail him at brian@lundinlawpc.com.

No class has been certified in the above action yet. Until a class is certified, you are not considered represented by an attorney. You may also choose to do nothing and be an absent class member.

According to the Complaint, throughout the Class Period, Acacia made materially false and/or misleading statements, and/or failed to disclose: that its manufacturing and quality control processes were deficient; that the foregoing deficiencies would likely disrupt the Company’s manufacturing and impact its revenues; and that as a result of the above, Acacia’s public statements were materially false and misleading at all relevant times.

On May 31, 2017, Acacia disclosed that ”the Company has identified a quality issue” affecting ”a portion” of several thousand modules manufactured by one of Acacia’s three contract manufacturers, citing as the ”root cause of this quality issue . . . a circuit board cleaning process that has since been eliminated.” On July 14, 2017, Acacia issued a press release announcing the Company’s preliminary financial and operating results for the quarter ended June 30, 2017. Acacia reported profit and revenue that missed estimates, and revised its current-quarter guidance downward. The Company stated that its ”second-quarter results were adversely affected by the quality issue identified at one of our three contract manufacturers that we announced on May 31.” When this information reached the public, shares of Acacia fell in value materially, which caused investors harm according to the Complaint.

Lundin Law PC was founded by Brian Lundin, Esq., a securities litigator based in Los Angeles dedicated to upholding shareholders’ rights.

This press release may be considered Attorney Advertising in certain jurisdictions under the applicable law and ethical rules.

Contact:

Lundin Law PC
Brian Lundin, Esq.
Telephone: 888-713-1033
Facsimile: 888-713-1125
brian@lundinlawpc.com
http://lundinlawpc.com/

SOURCE: Lundin Law PC

ReleaseID: 474225